RECBIO-B (02179) announced that the company has recently received a filing notice from the China Securities Regulatory Commission (CSRC) dated January 13, 2026, regarding its H-share full circulation plan.
According to the filing notice, the company has completed the filing with the CSRC for the conversion of a total of 142 million non-tradable shares held by 28 shareholders into H-shares.
The filing notice is valid for 12 months starting from January 13, 2026.
The company will apply to The Stock Exchange of Hong Kong for the approval to list and trade the relevant H-shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments